Clinical Trial Update: Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and immunogenicity of stored inactivated influenza H5N1 vaccine with and without stored MF59 adjuvant has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vietnam H5n1 Influenza

Snippet

Sponsor: Biomedical Advanced Research and Development Authority | Conditions: A/Vietnam/H5N1 Influenza Virus | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31